常規乳房篩檢攝影及低劑量胸部電腦斷層掃描檢查之輻射劑量風險綜合評估：假體研究

Assessment Radiation Dose Risk after Mammography Screening and LDCT: Phantom Study

白宗庭(Tsung-Ting Pai) ； 林佳陽(Cha-Yang Lin) ； 賴律翰(Lu-Han Lai) ； 王昱筌(Yu-Chuan Wang)

《台灣應用輻射與同位素雜誌》 19卷4期 (2023/12) Pp. 2275-2278

摘要

乳癌是台灣45至69歲女性最高癌症的發病率。乳房篩檢攝影有助於早期發現和早期治療。本研究評估要點為同時接受乳房篩檢攝影與低劑量電腦斷層檢查（Low-Dose computed tomography, LDCT）檢查的輻射劑量風險。雖然多數人早已將LDCT當肺部病兆篩檢選項之一，但因LDCT為自費檢查且存在輻射暴露風險，因此仍有疑慮不願意主動檢查。本研究使用光激發光劑量計（Optically Stimulated Luminescence Dosimeter, OSLD）綜合評估乳房篩檢攝影加上LDCT檢查的輻射劑量風險，因為風險非常低，因此建議較年長的女性，可以同時間進行乳房篩檢攝影加上LDCT的檢查。

關鍵字

乳房篩檢 ； 低劑量胸部電腦斷層 ； 輻射劑量

並列摘要

Breast cancer has the highest cancer incidence rate among women aged 45 to 69 in Taiwan. Mammography screening facilitates early detection and early treatment. This study evaluates the radiation dose risks of undergoing mammography screening and low-dose computed tomography (LDCT). Most people have already considered LDCT as one of the lung disease screenings. However, since LDCT is a self-funded examination and involves the risk of radiation exposure, there are still concerns and reluctance to take the initiative. This study uses Optically Stimulated Luminescence Dosimeter (OSLD) to comprehensively evaluate the radiation dose risk of mammography screening and LDCT examination. Because the risk is very low. Therefore, it is recommended that older women undergo mammography screening and LDCT at the same time.

並列關鍵字

Mammography Screening ； LDCT Examination ； Radiation Dose Risk

參考文獻

Medeiros, B., Allan, A. L. Molecular mechanisms of breast cancer metastasis to the lung: clinical and experimental perspectives. International journal of molecular sciences 2019, 20(9), 2272.

Nazari, S. S., Mukherjee, P. An overview of mammographic density and its association with breast cancer. Breast cancer 2018, 25, 259-267.

Patz, E. F., Greco, E., Gatsonis, C., Pinsky, P., Kramer, B. S., Aberle, D. R. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. The Lancet Oncology 2016, 17(5), 590-599.

Senan, S., Paul, M. A., Lagerwaard, F. J. Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative radiotherapy? The Lancet Oncology 2013, 14(7), 270-274.

Trapani, D., Ginsburg, O., Fadelu, T., Lin, N. U., Hassett, M., Ilbawi, A. M., Curigliano, G. Global challenges and policy solutions in breast cancer control. Cancer treatment reviews 2022, 104, 102339.